Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
486
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study

Takanori NumataDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2784-2331View further author information
ORCID Icon,
Jun ArayaDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Hanae MiyagawaDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-0527-4882View further author information
ORCID Icon,
Keitaro OkudaDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Daisuke TakekoshiDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Mitsuo HashimotoDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Shunsuke MinagawaDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Takeo IshikawaDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
,
Hiromichi HaraDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanView further author information
&
Kazuyoshi KuwanoDepartment of Respiratory Diseases, The Jikei University School of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0002-3729-1716View further author information
ORCID Icon show all
Pages 395-405 | Published online: 01 Apr 2022

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Takanori Numata, Jun Araya, Keitaro Okuda, Hanae Miyagawa, Shunsuke Minagawa, Takeo Ishikawa, Hiromichi Hara & Kazuyoshi Kuwano. (2022) Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study. Journal of Asthma and Allergy 15, pages 1731-1741.
Read now

Articles from other publishers (8)

Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, Yoshihiro Mori, Junko Itano, Akihiko Taniguchi, Satoru Senoo, Goro Kimura, Yasushi Tanimoto, Kohei Miyake, Tomoya Katsuta, Mikio Kataoka, Yoshinobu Maeda, Katsuyuki Kiura & Nobuaki Miyahara. (2023) Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study. Journal of Clinical Medicine 12:16, pages 5174.
Crossref
Giulia Scioscia, Santi Nolasco, Raffaele Campisi, Carla Maria Irene Quarato, Cristiano Caruso, Corrado Pelaia, Andrea Portacci & Claudia Crimi. (2023) Switching Biological Therapies in Severe Asthma. International Journal of Molecular Sciences 24:11, pages 9563.
Crossref
Koichi Fukunaga, Etsuko Tagaya, Masato Ishida, Yoshinori Sunaga, Ryuji Koshiba & Akihito Yokoyama. (2023) Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study. Allergology International.
Crossref
Corrado Pelaia, Alida Benfante, Maria Teresa Busceti, Maria Filomena Caiaffa, Raffaele Campisi, Giovanna Elisiana Carpagnano, Nunzio Crimi, Maria D’Amato, Maria Pia Foschino Barbaro, Angelantonio Maglio, Elena Minenna, Santi Nolasco, Giuseppe Paglino, Francesco Papia, Girolamo Pelaia, Andrea Portacci, Luisa Ricciardi, Nicola Scichilone, Giulia Scioscia, Massimo Triggiani, Giuseppe Valenti, Alessandro Vatrella & Claudia Crimi. (2023) Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps. Frontiers in Immunology 14.
Crossref
Rebecca Gall, Neal Jain, Weily Soong, Russell A. Settipane, Changming Xia, Yi Zhang, Tmirah Haselkorn, Juby A. Jacob-Nara & Shahid Siddiqui. (2023) Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry. Advances in Therapy 40:3, pages 1292-1298.
Crossref
Hiroyuki Nagase, Maho Suzukawa, Keiji Oishi & Kazuto Matsunaga. (2023) Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy. Allergology International 72:1, pages 11-23.
Crossref
Momoko Kurihara, Katsunori Masaki, Emiko Matsuyama, Masato Fujioka, Reina Hayashi, Saki Tomiyasu, Kotaro Sasahara, Keeya Sunata, Masato Asaoka, Yuto Akiyama, Miyuki Nishie, Misato Irie, Takae Tanosaki, Hiroki Kabata & Koichi Fukunaga. (2022) How Can Dupilumab Cause Eosinophilic Pneumonia?. Biomolecules 12:12, pages 1743.
Crossref
. (2022) Dupilumab. Reactions Weekly 1909:1, pages 229-229.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.